CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
ObjectiveHepatocellular carcinoma (HCC) is one of the most common malignant tumors endangering human health and life in the 21st century. Chromatin licensing and DNA replication factor 1 (CDT1) is an important regulator of DNA replication licensing, which is essential for initiation of DNA replicati...
Enregistré dans:
Auteurs principaux: | Chenhui Cai, Ying Zhang, Xu Hu, Wenhui Hu, Sizhen Yang, Hao Qiu, Tongwei Chu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9cd9969cd7b04373bd92fe650bed886b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
par: Chenhui Cai, et autres
Publié: (2021) -
Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
par: Yumei Fan, et autres
Publié: (2021) -
Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
par: Lin T, et autres
Publié: (2021) -
Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
par: Shuai Li, et autres
Publié: (2021) -
A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma
par: Qianqian Wu, et autres
Publié: (2021)